Sagimet Biosciences stock initiated with Buy rating at Clear Street
PositiveFinancial Markets

Sagimet Biosciences has received a Buy rating from Clear Street, signaling strong confidence in the company's future performance. This endorsement is significant as it may attract more investors and boost the stock's value, reflecting optimism about Sagimet's potential in the biotech sector.
— Curated by the World Pulse Now AI Editorial System